Chronic rejection: The result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosupressive therapies
暂无分享,去创建一个
[1] B. Kasiske,et al. Clinical correlates to chronic renal allograft rejection. , 1997, Kidney international. Supplement.
[2] R. Morris,et al. Progression of obliterative airway disease occurs despite the removal of immune reactivity by retransplantation. , 1997, Transplantation Proceedings.
[3] B. Portmann,et al. Graft and systemic disease in long‐term survivors of liver transplantation , 1997, Hepatology.
[4] G. Berry,et al. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis. , 1995, Transplantation proceedings.
[5] V. Dzau,et al. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. , 1995, Transplantation.
[6] R. Novick,et al. The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report--1998. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.